A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 242-249

  Kitakaze, Masafumi ^a   Node, Koichi ^a   Minamino, Tetsuo ^a   Asanuma, Hiroshi ^a   Kuzuya, Tsunehiko ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INTRACORONARY INFUSION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; DIHYDROPYRIDINES; DOGS; ENERGY METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; VASODILATION;

EID: 0032920058     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00556-7     Document Type: Article

References (36)

1. Maseri A, Chierchia S. Coronary artery spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Disease 1982;25:169-92.
2. Opie LH. Should calcium antagonist be used after myocardial infarction? Ischemia selectivity versus vascular selectivity. Cardiovasc Drugs Ther 1993;6:19-24.
3. 2+ antagonist-induced vasodilation - intracellular actions. Circ Res 1983;52:137-42.
4. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996;28:58-63.
5. Karasawa A, Rochester A, Lefer A. Protection of endothelial damage and systemic shock by benidipine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion. Circ Shock 1991;33:135-41.
6. Bassenge E, Heusch G. Endothelial and neurohumoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol 1990;116:77-165.
7. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Toxicol 1990;30:535-60.
8. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Decreased plasma levels of nitric oxide in patients with essential hypertension. Hypertension 1997;30:405-8.
9. Fujimura Y, Tsuboi H, Esato K. Efficacy of benidipine hydrochloride on myocardial ischemia and reperfusion. J Surg Res 1995;59:321-5.
10. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-H22.
11. Willerson JT. Serotonin and thrombotic complications. J Cardiovasc Pharmacol 1991;17:S13-S20.
12. Marangos PJ, Fintel MS, Verma A, Maturi MF, Patel J, Patterson RE. Adenosine uptake sites in dog heart and brain; interaction with calcium antagonist. Life Sciences 1984;35:1109-16.
13. Rovetto MJ, Ford DA, Yassin A. Cardiac myocyte and coronary endothelial cell adenosine transport. In: Gerlach E, Becker BF, editors. Topics and Perspective in Adenosine Research. Berlin, Heidelberg: Springer-Verlag, 1987:188-98.
14. Abel FL. Maximal negative dP/dt as an indicator of end of systole. Am J Physiol 1981;240:H676-9.
15. Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988;78:729-35.
16. Schaefer S, Schwartz GG, Wisneski JA, et al. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation 1992;85:342-9.
17. Bergmeyr HU. Methods of Enzymatic Analysis. 1st ed. New York: Academic Press, 1963.
18. Kitakaze M, Node K, Minamino T, et al. Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs. J Am Coll Cardiol 1996;27:1804-12.
19. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
20. Kosaka H, Tsuda M, Kurashima Y, et al. Marked nitration by stimulation with lipopolysaccaride in ascorbic acid-deficient rats. Carcinogenesis 1990; 11:1887-9.
21. Yamane R, Nakamura T, Matsuura E, Ishige H, Fujimoto M. A simple and sensitive radioimmunoassay for adenosine. J Immunoassay 1991;12:501-19.
22. Steiner AL, Pagliara AS, Chase LR, Kipnis DM. Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′, 5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissues and body fluids. J Biol Chem 1972;247:1114-20.
23. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samplings from blood and tissue. Biochem Med 1977;18:257-73.
24. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames: Iowa State University Press, 1972.
25. Steel RGD, Torrie JH. Principle and Procedures of Statistics: A Biomedical Approach. 2nd ed. New York: McGraw-Hill, 1980.
26. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels. An unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998;97:576-80.
27. Hori M, Kitakaze M. Adenosine, the heart and coronary circulation (brief review). Hypertension 1991;18:565-74.
28. + channel in cultured bovine aortic endothelial cells. Pflügers Arch 1988;412:469-81.
29. + channels regulates coronary blood flow in ischemic myocardium. Circulation 1997;95:1560-7.
30. Yoshida K, Kohzuki M, Yasujima M, Kanazawa M, Abe K. Effects of benidipine, a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes. J Hypertension 1996;14:215-22.
31. Smith TP, Canty JM. Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993;73:232-40.
32. Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravate myocardial hypoperfusion during exercise in the presence of a coronary stenosis. Circ Res 1994;74:629-40.
33. Canty JM, Smith TP. Adenosine-recruitable flow reserve is absent during myocardial ischemia in unanesthetized dogs studied in the basal state. Circ Res 1995;76:1079-87.
34. Li WJ, Kitakaze M, Minamino T, Node K, Hori M. Nitric oxide opens the second window of cardioprotection of ischemic preconditioning: role of induction of heat shock protein (HSP72). J Am Coll Cardiol 1997;29:12A.
35. Qui Y, Tang XL, Manchikalapudi S, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 1997;273:H2931-6.
36. Bolli R, Bhatti ZA, Tang XL, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 1997;81:42-52.